Newsfeeds Archive - Spark Newswire

1 minute read

Events
News

Nanobiotix Announced New Data At ASCO 2924, Showing 48% ORR In Evaluable Anti-PD-1 Naïve Patients (n=25); 28% ORR In Evaluable Anti-PD-1 Resistant Patients (n=25) As Per RECIST 1.1

June 2, 10:42 AM

NANOBIOTIX (NASDAQ:NBTX) today announced new data from Study 1100, a US Phase 1 dose escalation and dose expansion study evaluating radiotherapy-activated NBTXR3 followed by anti-PD-1 immune checkpoint

NBTX

1 minute read

NANOBIOTIX To Present Of new Data From Phase 1 Immunotherapy Program At The 2024 ASCO Annual Meeting Followed By An Investor Conference Call

By Benzinga Newsdesk

May 28, 4:21 PM

New data from the completed dose escalation part and ongoing expansion part of Study 1100, an ongoing US Phase 1 study evaluating NBTXR3 followed by anti-PD-1 in patients with recurrent or metastatic head and neck cancer

NBTX

4 minute read

Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Avi Kapoor

May 22, 1:28 PM

Shares of XP Inc. (NASDAQ:XP) fell sharply during Wednesday’s session after the company reported worse-than-expected first-quarter EPS results.…

ADI

1 minute read

Nanobiotix Reports Updates For Global NBTXR3 Development Collaboration Highlighting Robust Pipeline And Pathway To Long-Term Growth

By Benzinga Newsdesk

May 21, 4:20 PM

Updated Nanobiotix corporate strategy designed to enable long-term growth through execution of the global NBTXR3 collaboration and platforms beyond NBTXR3Alignment of intent to transfer the sponsorship of the ongoing

NBTX

2 minute read

CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session

By Avi Kapoor

Yesterday, 8:03 AM

U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Thursday.

FAAS

2 minute read

Nanobiotix Announces Completion Of Phase 1 Dose Escalation And NBTXR3 Recommended Phase 2 Dose For The Treatment Of Inoperable, Recurrent Lung Cancer In Patients Amenable To Re-Irradiation

By Benzinga Newsdesk

April 2, 4:17 PM

Established recommended Phase 2 dose of NBTXR3 for the treatment of patients with inoperable, recurrent non-small cell lung cancer ("NSCLC") who have previously received definitive radiation therapyConfirmation of

NBTX

2 minute read

General Motors Posts Upbeat Earnings, Joins Corning, HCA Healthcare And Other Big Stocks Moving Higher On Tuesday

By Avi Kapoor

January 30, 11:09 AM

U.S. stocks traded slightly lower, with the Dow Jones falling around 20 points on Tuesday.

AAOI

1 minute read

Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

By Avi Kapoor

January 3, 7:14 AM

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 60 points on Wednesday. Shares of Pinstripes (NYSE: PNST) shares fell in pre-market trading after surging 22% on Tuesday.

AUR